Reports
Global Dengue Testing Market: By Product Type: ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others; By End User: Hospitals, Diagnostic Centres, Others; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Dengue Testing Market Outlook
The global dengue testing market stood at a value of around USD 456.2 million in 2020. The market is further expected to grow in the forecast period of 2023-2028 at a CAGR of 4.63% to reach USD 598.4 million by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
ELISA-Based Tests Predicted to Dominate the Product Type Segment Over the Forecast Period
Based on product type, ELISA-based tests are predicted to dominate the industry during the forecast period. Enzyme linked immunosorbent assay (ELISA) is one of the widely accepted methods for diagnosing dengue virus. The early diagnosis and management of dengue virus can lower the mortality rates from severe forms of the disease. When compared to other testing methods, ELISA kits have high sensitivity and superior performance. Due to their high efficiency and sensitivity, ELISA has become the recommended diagnostic choice.
The Asia Pacific to Hold a Significant Market Share in the Dengue Testing Industry During the Forecast Period
Geographically, the Asia Pacific is predicted to hold a significant market share in the dengue virus testing industry during the forecast period due to the increasing number of dengue cases in the region. Change in the climatic condition and lack of hygiene and proper wastewater management techniques are key factors causing an increase in dengue cases, thus, propelling the demand for dengue testing.
Dengue Testing: Market Segmentation
Dengue testing determines whether a person with dengue related symptoms has been infected with the dengue virus. The infection is difficult to diagnose without lab tests because symptoms may look similar to those of other diseases, such as chikungunya infection.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product type, the industry can be segmented into:
- ELISA-based Tests
- RT-PCR based Tests
- Dengue IgG/IgM Rapid Test
- Others
Based on end user, the industry can be segmented into:
- Hospitals
- Diagnostic Centres
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rise in Number of Dengue Cases to Bolster the Growth of the Global Dengue Testing Industry
The global market for dengue testing has been growing considerably for the last few years. The rise in the number of dengue cases has enhanced the demand for diagnostic kits. Moreover, the increasing research and development activities to develop highly sensitive and specific dengue diagnostic kits are also expected to drive the growth of the market. In addition, the improving healthcare infrastructure and the growing availability of diagnostic centres in emerging countries are expected to further propel the market growth in the forecast period.
Key Industry Players in the Global Dengue Testing Market
The report gives a detailed analysis of the following key players in the global dengue testing market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Abbott Laboratories
- Abnova Corporation
- F. Hoffmann-La Roche Ltd.
- Diasorin S.p.A.
- InBios International, Inc
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type, End User, Region |
| Breakup by Product Type | ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, Others |
| Breakup by End User | Hospitals, Diagnostic Centres, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott Laboratories, Abnova Corporation, F. Hoffmann-La Roche Ltd., Diasorin S.p.A., InBios International, Inc, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Dengue Testing Market Analysis
8.1 Key Industry Highlights
8.2 Global Dengue Testing Historical Market (2018-2022)
8.3 Global Dengue Testing Market Forecast (2023-2028)
8.4 Global Dengue Testing Market by Product Type
8.4.1 ELISA-based Tests
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 RT-PCR based Tests
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.4.3 Dengue IgG/IgM Rapid Test
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2018-2022)
8.4.3.3 Forecast Trend (2023-2028)
8.4.4 Others
8.5 Global Dengue Testing Market by End User
8.5.1 Hospitals
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Diagnostic Centres
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Others
8.6 Global Dengue Testing Market by Region
8.6.1 North America
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Europe
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Asia Pacific
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Latin America
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Middle East and Africa
8.6.5.1 Market Share
8.6.5.2 Historical Trend (2018-2022)
8.6.5.3 Forecast Trend (2023-2028)
9 North America Dengue Testing Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Dengue Testing Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Dengue Testing Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Dengue Testing Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Dengue Testing Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Abbott Laboratories
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Abnova Corporation
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 F. Hoffmann-La Roche Ltd.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Diasorin S.p.A.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 InBios International, Inc
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Dengue Testing Market: Key Industry Highlights, 2018 and 2028
2. Global Dengue Testing Historical Market: Breakup by Product Type (USD Million), 2018-2022
3. Global Dengue Testing Market Forecast: Breakup by Product Type (USD Million), 2023-2028
4. Global Dengue Testing Historical Market: Breakup by End User (USD Million), 2018-2022
5. Global Dengue Testing Market Forecast: Breakup by End User (USD Million), 2023-2028
6. Global Dengue Testing Historical Market: Breakup by Region (USD Million), 2018-2022
7. Global Dengue Testing Market Forecast: Breakup by Region (USD Million), 2023-2028
8. North America Dengue Testing Historical Market: Breakup by Country (USD Million), 2018-2022
9. North America Dengue Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
10. Europe Dengue Testing Historical Market: Breakup by Country (USD Million), 2018-2022
11. Europe Dengue Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Asia Pacific Dengue Testing Historical Market: Breakup by Country (USD Million), 2018-2022
13. Asia Pacific Dengue Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
14. Latin America Dengue Testing Historical Market: Breakup by Country (USD Million), 2018-2022
15. Latin America Dengue Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
16. Middle East and Africa Dengue Testing Historical Market: Breakup by Country (USD Million), 2018-2022
17. Middle East and Africa Dengue Testing Market Forecast: Breakup by Country (USD Million), 2023-2028
18. Global Dengue Testing Market Structure
Key Questions Answered in the Report
In 2020, the global dengue testing market attained a value of nearly USD 456.2 million.
The market is projected to grow at a CAGR of 4.63% between 2023 and 2028.
The major drivers include the increasing research and development activities, growing availability of diagnostic centres, change in the climatic conditions and lack of hygiene and proper wastewater management techniques.
The key market trends guiding the growth of the industry include the rise in the number of dengue cases and improving healthcare infrastructure.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with Asia Pacific accounting for the largest share in the market.
ELISA-based tests, RT-PCR based tests, and dengue IgG/IgM rapid test, among others are the significant product types in the market.
Hospitals and diagnostic centres, among others are the major end users of product in the industry.
The major players in the industry are Abbott Laboratories, Abnova Corporation, F. Hoffmann-La Roche Ltd., Diasorin S.p.A., and InBios International, Inc, among others.
Analyst Review
The global dengue testing market attained a value of USD 456.2 million in 2020, driven by the rise in the number of dengue cases. Aided by increasing research and development related activities to develop highly sensitive and specific dengue diagnostic kits and growing availability of diagnostic centres, the market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 4.63%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its product type, the dengue testing industry can be segmented into ELISA-based tests, RT-PCR based tests, and dengue IgG/IgM rapid test, among others. Based on its end user, the dengue testing industry can be segmented into hospital and diagnostics centres, among others. The major regional markets for dengue testing are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories, Abnova Corporation, F. Hoffmann-La Roche Ltd., Diasorin S.p.A., and InBios International, Inc, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2799-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
NEWSLETTER